Safety and Efficacy of RAD001 (Everolimus) in Combination With Letrozole in the Treatment of Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

Clinical trial NCT01231659 · COMPLETED

Trial details

NCT number

NCT01231659

Sponsor

Novartis Pharmaceuticals

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2011-08-09

Primary completion

2012-11-20

Enrollment

72

View on ClinicalTrials.gov